- Home
- CARG vs VRNA Comparison
CARG vs VRNA Comparison
Compare CARG & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARG
- VRNA
- Stock Information
- Founded
- CARG 2005
- VRNA 2005
- Country
- CARG United States
- VRNA United Kingdom
- Employees
- CARG N/A
- VRNA N/A
- Industry
- CARG EDP Services
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- CARG Technology
- VRNA Health Care
- Exchange
- CARG Nasdaq
- VRNA Nasdaq
- Market Cap
- CARG 3.7B
- VRNA 3.2B
- IPO Year
- CARG 2017
- VRNA 2017
- Fundamental
- Price
- CARG $37.14
- VRNA $41.66
- Analyst Decision
- CARG Buy
- VRNA Strong Buy
- Analyst Count
- CARG 11
- VRNA 6
- Target Price
- CARG $37.86
- VRNA $43.83
- AVG Volume (30 Days)
- CARG 622.2K
- VRNA 1.0M
- Earning Date
- CARG 11-07-2024
- VRNA 11-04-2024
- Dividend Yield
- CARG N/A
- VRNA N/A
- EPS Growth
- CARG N/A
- VRNA N/A
- EPS
- CARG N/A
- VRNA N/A
- Revenue
- CARG $888,969,000.00
- VRNA $5,624,000.00
- Revenue This Year
- CARG $0.09
- VRNA N/A
- Revenue Next Year
- CARG $9.39
- VRNA $644.06
- P/E Ratio
- CARG N/A
- VRNA N/A
- Revenue Growth
- CARG N/A
- VRNA 1127.95
- 52 Week Low
- CARG $21.18
- VRNA $11.39
- 52 Week High
- CARG $39.10
- VRNA $43.73
- Technical
- Relative Strength Index (RSI)
- CARG 54.15
- VRNA 61.99
- Support Level
- CARG $37.41
- VRNA $38.77
- Resistance Level
- CARG $38.69
- VRNA $43.73
- Average True Range (ATR)
- CARG 0.90
- VRNA 1.41
- MACD
- CARG -0.23
- VRNA 0.07
- Stochastic Oscillator
- CARG 23.14
- VRNA 60.80
About CARG CarGurus Inc.
CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listing through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments namely U.S. Marketplace and Digital Wholesale. It generates majority of revenue from the U.S. Marketplace.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.